Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform
Real-Time, Risk-Based Clinical Trial Quality Management in China: Development of a Digital Monitoring Platform
Min Jiang
1
* , MSc ;
Shuhua Zhao
2
* , MSc ;
Yun Mei
3
, MSc ;
Zhiying Fu
2
, MSc ;
Yannan Yuan
2
, MSc ;
Jie Ai
3
, MSc ;
Yuan Sheng
4
, PhD ;
Ying Gong
4
, BSc ;
Jingjing Chen
4
, MSc
1
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute, Beijing, China
2
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute, Beijing, China
3
Yidu Cloud (Beijing) Technology Co, Ltd, Beijing, China
4
Pfizer (China) Research and Development Co, Ltd, Shanghai, China
*these authors contributed equally
Corresponding Author:
-
Min Jiang, MSc
-
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers
-
Beijing Key Laboratory of Carcinogenesis and Translational Research, National Drug Clinical Trial Center, Peking University Cancer Hospital & Institute
-
52 Fucheng Rd, Haidian District
-
Beijing
-
China
-
Phone:
86 01088196664
-
Email: gcp_jiangm@bjcancer.org.cn